Metacrine, Inc.
MTCR · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $1 |
| % Margin | – | – | – | 100% |
| R&D Expenses | $45 | $27 | $26 | $23 |
| G&A Expenses | $16 | $10 | $4 | $5 |
| SG&A Expenses | $16 | $10 | $4 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $61 | $37 | $30 | $28 |
| Operating Income | -$61 | -$37 | -$30 | -$27 |
| % Margin | – | – | – | -1,843.4% |
| Other Income/Exp. Net | -$1 | -$1 | $1 | $1 |
| Pre-Tax Income | -$62 | -$37 | -$29 | -$26 |
| Tax Expense | -$1 | -$1 | $0 | $0 |
| Net Income | -$61 | -$36 | -$29 | -$26 |
| % Margin | – | – | – | -1,780.8% |
| EPS | -1.45 | -3.87 | -1.52 | -1.35 |
| % Growth | 62.5% | -154.6% | -12.6% | – |
| EPS Diluted | -1.45 | -3.87 | -1.52 | -1.35 |
| Weighted Avg Shares Out | 42 | 9 | 19 | 19 |
| Weighted Avg Shares Out Dil | 42 | 9 | 19 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $2 | $1 |
| EBITDA | -$60 | -$35 | -$28 | -$25 |
| % Margin | – | – | – | -1,723.6% |